Solana Company logo

Solana Company (HSDT)

Market Closed
5 Dec, 20:00
NASDAQ (CM) NASDAQ (CM)
$
3. 86
-0.34
-8.1%
$
161.6M Market Cap
- P/E Ratio
0% Div Yield
406,768 Volume
-16.71 Eps
$ 4.2
Previous Close
Day Range
3.83 4.12
Year Range
2.83 1,200
Want to track HSDT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

HSDT closed Friday lower at $3.86, a decrease of 8.1% from Thursday's close, completing a monthly decrease of -6.08% or $0.25. Over the past 12 months, HSDT stock lost -99.23%.
HSDT is not paying dividends to its shareholders.
The last earnings report, released on Nov 18, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Solana Company has completed 5 stock splits, with the recent split occurring on Jul 01, 2025.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

HSDT Chart

Solana Company (HSDT) Q3 2025 Earnings Call Transcript

Solana Company (HSDT) Q3 2025 Earnings Call Transcript

Solana Company ( HSDT ) Q3 2025 Earnings Call November 18, 2025 4:30 PM EST Company Participants Choon Wee Chee - Executive Chairman Cosmo Jiang Dane Andreeff - President, CEO & Director Jeff Mathiesen - CFO, Treasurer & Secretary Presentation Operator Hello, and thank you for standing by. Welcome to Solana Company's Third Quarter Operating Results Conference Call.

Seekingalpha | 2 weeks ago
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference

Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference

NEWTOWN, Pa., Oct. 18, 2024 – PRISM MediaWire – Helius Medical Technologies, Inc.

Prismmediawire | 1 year ago
Helius Medical Technologies, Inc. (HSDT) Q2 2024 Earnings Call Transcript

Helius Medical Technologies, Inc. (HSDT) Q2 2024 Earnings Call Transcript

Helius Medical Technologies, Inc. (NASDAQ:HSDT ) Q2 2024 Results Conference Call August 12, 2024 4:30 PM ET Company Participants Michelle Bilski - IR Dane Andreeff - President and CO Jeff Mathiesen - CFO Conference Call Participants Anthony Vendetti - Maxim Group Operator Good day, and thank you for standing by. Welcome to the Helius Medical Technologies Second Quarter 2024 Earnings Conference Call [Operator Instructions].

Seekingalpha | 1 year ago

Solana Company (HSDT) FAQ

What is the stock price today?

The current price is $3.86.

On which exchange is it traded?

Solana Company is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is HSDT.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 161.6M.

Has Solana Company ever had a stock split?

Solana Company had 5 splits and the recent split was on Jul 01, 2025.

Solana Company Profile

- Industry
- Sector
Dane Carl Andreeff CEO
NASDAQ (CM) Exchange
42328V876 CUSIP
US Country
21 Employees
- Last Dividend
1 Jul 2025 Last Split
27 Jun 2014 IPO Date

Overview

Helius Medical Technologies, Inc. stands out as a pioneering company in the realm of neurotechnology with its focus straddling the development, licensing, and procurement of innovative non-implantable technologies aimed at ameliorating symptoms attributable to neurological disorders or injuries. Founded in 2014, this firm has set its base in Newtown, Pennsylvania, marking its commitment towards delivering groundbreaking solutions to enhance neurological health and function.

Products and Services

  • Portable Neuromodulation Stimulator (PoNS™)

This avant-garde, non-surgical medical device represents Helius Medical Technologies' flagship offering. It’s specifically engineered for short-term treatment of gait deficits stemming from multiple sclerosis and balance deficits due to mild-to-moderate traumatic brain injury. A key aspect of its application involves concurrent utilization with supervised therapeutic exercises, highlighting its role as a supplementary treatment modality designed to foster improved neurological function.

Contact Information

Address: 642 Newtown Yardley Road
Phone: 215 944 6100